HSPA4L

gene
On this page

Also known as APG-1Osp94HSPH3

Summary

HSPA4L (heat shock protein family A (Hsp70) member 4 like, HGNC:17041) is a protein-coding gene on chromosome 4q28.1, encoding Heat shock 70 kDa protein 4L (O95757). Possesses chaperone activity in vitro where it inhibits aggregation of citrate synthase.

The protein encoded by this gene is heat shock inducible and may act as a chaperone. The encoded protein can protect the heat-shocked cell against the harmful effects of aggregated proteins. This gene is highly expressed in leukemia cells and may be a good target for therapeutic intervention. Several transcripts encoding different isoforms have been found for this gene.

Source: NCBI Gene 22824 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 127 total
  • Druggable target: yes
  • MANE Select transcript: NM_014278

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:17041
Approved symbolHSPA4L
Nameheat shock protein family A (Hsp70) member 4 like
Location4q28.1
Locus typegene with protein product
StatusApproved
AliasesAPG-1, Osp94, HSPH3
Ensembl geneENSG00000164070
Ensembl biotypeprotein_coding
OMIM619077
Entrez22824

Gene structure

Transcript identifiers

Ensembl transcripts: 6 — 5 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000296464, ENST00000505726, ENST00000508549, ENST00000508776, ENST00000515262, ENST00000883836

RefSeq mRNA: 4 — MANE Select: NM_014278 NM_001317381, NM_001317382, NM_001317383, NM_014278

CCDS: CCDS3734, CCDS82953

Canonical transcript exons

ENST00000296464 — 19 exons

ExonStartEnd
ENSE00001081079127803629127803873
ENSE00001081080127801138127801237
ENSE00001081081127827305127827424
ENSE00001081082127798587127798709
ENSE00001081084127830638127830799
ENSE00001081085127805073127805224
ENSE00001081086127805687127805793
ENSE00001081089127811437127811636
ENSE00001081091127822769127822894
ENSE00001081093127795768127795908
ENSE00001081095127807996127808129
ENSE00001081097127794077127794134
ENSE00001081099127804011127804087
ENSE00001081101127823517127823624
ENSE00001081103127820428127820565
ENSE00001922654127782322127782657
ENSE00001923629127832683127840733
ENSE00002478089127801785127801918
ENSE00003480767127818325127818420

Expression profiles

Bgee: expression breadth ubiquitous, 254 present calls, max score 99.63.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 9.3183 / max 209.0510, expressed in 1394 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
496059.09201389
496060.186385
496030.02158
496040.01853

Top tissues by expression

293 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
spermCL:000001999.63gold quality
male germ cellCL:000001597.31gold quality
left testisUBERON:000453396.12gold quality
right testisUBERON:000453496.00gold quality
testisUBERON:000047393.61gold quality
adrenal tissueUBERON:001830392.65gold quality
Brodmann (1909) area 23UBERON:001355489.71gold quality
secondary oocyteCL:000065589.47gold quality
postcentral gyrusUBERON:000258187.86gold quality
ponsUBERON:000098887.85gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099187.03gold quality
adult organismUBERON:000702386.41gold quality
substantia nigra pars compactaUBERON:000196586.07gold quality
bronchial epithelial cellCL:000232885.86gold quality
primary visual cortexUBERON:000243685.60gold quality
lateral nuclear group of thalamusUBERON:000273685.27gold quality
parietal lobeUBERON:000187285.26gold quality
superior frontal gyrusUBERON:000266185.04gold quality
islet of LangerhansUBERON:000000684.47gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047384.45gold quality
choroid plexus epitheliumUBERON:000391183.65gold quality
entorhinal cortexUBERON:000272883.12gold quality
ventricular zoneUBERON:000305382.98gold quality
calcaneal tendonUBERON:000370182.84gold quality
esophagus mucosaUBERON:000246982.80gold quality
gingivaUBERON:000182882.62gold quality
middle temporal gyrusUBERON:000277182.52gold quality
superior vestibular nucleusUBERON:000722782.33gold quality
gingival epitheliumUBERON:000194982.27gold quality
occipital lobeUBERON:000202182.27gold quality

Single-cell (SCXA)

Detected in 5 experiment(s), a significant marker in 4.

ExperimentMarker?Max mean expression
E-CURD-112yes3781.94
E-HCAD-25yes9.58
E-GEOD-93593yes6.89
E-GEOD-124858no60.13
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

92 targeting HSPA4L, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-126-5P100.0072.713180
HSA-MIR-3163100.0077.238605
HSA-MIR-29A-3P100.0073.111835
HSA-MIR-29B-3P100.0073.181833
HSA-MIR-29C-3P100.0073.151833
HSA-MIR-480399.9871.993117
HSA-MIR-569699.9872.364487
HSA-MIR-60799.9773.625593
HSA-MIR-365899.9673.874379
HSA-MIR-551B-5P99.9671.283493
HSA-MIR-4760-3P99.9370.502385
HSA-MIR-314399.9371.963104
HSA-MIR-497-5P99.9271.832674
HSA-MIR-6508-5P99.9270.672465
HSA-MIR-130599.9171.433443
HSA-MIR-7-1-3P99.9171.534384
HSA-MIR-7-2-3P99.9171.404394
HSA-MIR-806399.9169.763146
HSA-MIR-129799.9173.413162
HSA-MIR-808799.9069.551351
HSA-MIR-195-5P99.9072.812805
HSA-MIR-15A-5P99.9072.802787
HSA-MIR-15B-5P99.9072.782798
HSA-MIR-16-5P99.9072.802780
HSA-MIR-380-3P99.8970.181978
HSA-MIR-424-5P99.8971.902641
HSA-MIR-6838-5P99.8971.942690
HSA-MIR-579-3P99.8671.663628
HSA-MIR-806799.8669.592260
HSA-MIR-664B-3P99.8471.653590

Literature-anchored findings (GeneRIF, showing 7)

  • a novel autocrine pathway of CD1d regulation by Hsp110. (PMID:12952923)
  • Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis. (PMID:21946539)
  • Human molecular chaperone Hsp110 rescues a vesicle transport defect produced by an ALS-associated mutant SOD1 protein in squid axoplasm. (PMID:23509252)
  • HSP40 and HSP110 function together in protein homeostasis control. (PMID:24091676)
  • Findings indicate that miR-497 is a potent tumor suppressor that inhibits cancer phenotypes by targeting ANLN and HSPA4L in NPC. (PMID:26486082)
  • decreased expression of HSPA4L in immature and asthenozoospermic spermatozoa was validated by western blot analysis. Functional analysis revealed a correlation between HSPA4L and sperm motility by Spearman correlation analysis and its involvement in sperm-oocyte penetration by the human sperm-hamster egg penetration test. (PMID:30637842)
  • Apg-1 knockdown sensitized myeloma cells to bortezomib treatment, which may provide a new approach in multiple myeloma treatment. (PMID:31899217)

Cross-species orthologs

8 orthologs

OrganismSymbolGene ID
danio_reriohspa4lENSDARG00000053544
mus_musculusHspa4lENSMUSG00000025757
rattus_norvegicusHspa4lENSRNOG00000010819
drosophila_melanogasterHsp110FBGN0026418
caenorhabditis_eleganshsp-70WBGENE00002026
caenorhabditis_elegansWBGENE00009691
caenorhabditis_elegansWBGENE00009692
caenorhabditis_elegansWBGENE00016250

Paralogs (13): HSPA5 (ENSG00000044574), HSPA8 (ENSG00000109971), HSPA9 (ENSG00000113013), HSPH1 (ENSG00000120694), HSPA2 (ENSG00000126803), HYOU1 (ENSG00000149428), HSPA13 (ENSG00000155304), HSPA4 (ENSG00000170606), HSPA6 (ENSG00000173110), HSPA14 (ENSG00000187522), HSPA1B (ENSG00000204388), HSPA1A (ENSG00000204389), HSPA1L (ENSG00000204390)

Protein

Protein identifiers

Heat shock 70 kDa protein 4LO95757 (reviewed: O95757)

Alternative names: Heat shock 70-related protein APG-1, Heat shock protein family H member 3, Heat-shock protein family A member 4-like protein, Osmotic stress protein 94

All UniProt accessions (4): A0A140VKE7, D6RJ96, E9PDE8, O95757

UniProt curated annotations — full annotation on UniProt →

Function. Possesses chaperone activity in vitro where it inhibits aggregation of citrate synthase.

Subunit / interactions. Homodimer.

Subcellular location. Cytoplasm. Nucleus.

Induction. By heat shock and osmotic imbalance.

Similarity. Belongs to the heat shock protein 70 family.

RefSeq proteins (4): NP_001304310, NP_001304311, NP_001304312, NP_055093* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR013126Hsp_70_famFamily
IPR018181Heat_shock_70_CSConserved_site
IPR029047HSP70_peptide-bd_sfHomologous_superfamily
IPR029048HSP70_C_sfHomologous_superfamily
IPR042708HSPA4L_NBDDomain
IPR043129ATPase_NBDHomologous_superfamily

Pfam: PF00012

UniProt features (15 total): modified residue 5, sequence variant 3, compositionally biased region 3, region of interest 2, chain 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O95757-F186.230.77

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (5): 761, 74, 508, 545, 579

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-3371453Regulation of HSF1-mediated heat shock response

MSigDB gene sets: 219 (showing top): LEE_NEURAL_CREST_STEM_CELL_DN, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, IVANOVA_HEMATOPOIESIS_MATURE_CELL, BROWNE_HCMV_INFECTION_16HR_UP, GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, MAHAJAN_RESPONSE_TO_IL1A_DN, GOBP_PROTEIN_MATURATION, CADWELL_ATG16L1_TARGETS_DN, KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP, GOBP_PROTEIN_FOLDING, NEMETH_INFLAMMATORY_RESPONSE_LPS_DN, FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN

GO Biological Process (2): protein folding (GO:0006457), response to unfolded protein (GO:0006986)

GO Molecular Function (4): adenyl-nucleotide exchange factor activity (GO:0000774), ATP binding (GO:0005524), ATP-dependent protein folding chaperone (GO:0140662), nucleotide binding (GO:0000166)

GO Cellular Component (3): nucleus (GO:0005634), cytoplasm (GO:0005737), cytosol (GO:0005829)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Cellular response to heat stress1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
cellular process1
protein maturation1
response to topologically incorrect protein1
ATP binding1
ADP binding1
ATPase regulator activity1
adenyl ribonucleotide binding1
purine ribonucleoside triphosphate binding1
protein folding chaperone1
ATP-dependent activity1
nucleoside phosphate binding1
heterocyclic compound binding1
intracellular membrane-bounded organelle1
intracellular anatomical structure1
cytoplasm1

Protein interactions and networks

STRING

3822 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
HSPA4LHSP90AA1P07900687
HSPA4LHSP90AB1P08238676
HSPA4LHSPA12AO43301632
HSPA4LDNAJA1P31689596
HSPA4LHSPE1P61604574
HSPA4LHSPA12BQ96MM6546
HSPA4LDNAJB1P25685532
HSPA4LHSP90B1P14625530
HSPA4LDNAJA4Q8WW22495
HSPA4LDNAJA2O60884494
HSPA4LDNAJB4Q9UDY4488
HSPA4LHSPA5P11021450
HSPA4LHSPB2Q16082447
HSPA4LPRPF31Q8WWY3444
HSPA4LSUSD1Q6UWL2439

IntAct

154 interactions, top by confidence:

ABTypeScore
TTC1VAPBpsi-mi:“MI:0914”(association)0.790
YAP1MPDZpsi-mi:“MI:0914”(association)0.780
CFTRESYT2psi-mi:“MI:2364”(proximity)0.710
CFTRESYT2psi-mi:“MI:0914”(association)0.710
HSF1KPNA3psi-mi:“MI:0914”(association)0.640
IGF1RPIK3R2psi-mi:“MI:2364”(proximity)0.590
INSRPIK3R2psi-mi:“MI:2364”(proximity)0.570
NHNRNPDLpsi-mi:“MI:0914”(association)0.530
CREB1HSPA4Lpsi-mi:“MI:0914”(association)0.530
P/VIRS4psi-mi:“MI:0914”(association)0.530
P/VHSPA4Lpsi-mi:“MI:0914”(association)0.530
STUB1DNAJB6psi-mi:“MI:0914”(association)0.530
HSPA8ARHGEF10psi-mi:“MI:2364”(proximity)0.480
SCLT1CCDC22psi-mi:“MI:0914”(association)0.420
HNF1AHSPA4Lpsi-mi:“MI:0914”(association)0.420
AATKNDUFA4psi-mi:“MI:0914”(association)0.420
TNFAIP3LRRIQ3psi-mi:“MI:0914”(association)0.420
OTUB1EPM2Apsi-mi:“MI:0914”(association)0.350
MagohTRAPPC13psi-mi:“MI:0914”(association)0.350
HSPA5NCOR2psi-mi:“MI:0914”(association)0.350
SF1U2SURPpsi-mi:“MI:0914”(association)0.350
JUNTPM3psi-mi:“MI:0914”(association)0.350

BioGRID (347): HSPA4L (Affinity Capture-MS), HSPA4L (Affinity Capture-MS), HSPA4L (Affinity Capture-MS), DNAJA1 (Co-fractionation), DNAJA2 (Co-fractionation), DNAJA4 (Co-fractionation), DNAJB1 (Co-fractionation), DNAJC10 (Co-fractionation), DNAJC9 (Co-fractionation), HINT1 (Co-fractionation), HSPA4L (Co-fractionation), HSPA4L (Co-fractionation), HSPA4L (Co-fractionation), HSPA4L (Co-fractionation), HSPA4L (Co-fractionation)

ESM2 similar proteins: A2X6S3, A2YR10, A4FUX8, O88600, O94805, O95757, O96019, P30172, P32390, P34932, P42528, P47117, P48722, P53458, P53490, P78712, P81228, P81229, P86173, P93372, P93374, P93375, Q0IEG8, Q0IIM3, Q2TFN9, Q4R333, Q5R606, Q5R8R4, Q5RDM4, Q60446, Q61316, Q61699, Q61WW9, Q66HA8, Q69YN2, Q6K908, Q6ZJW9, Q84M92, Q92598, Q96482

Diamond homologs: A2Q0Z1, A5A8V7, F4HQD4, O59838, O59855, O65719, O73885, O74225, O88600, O93866, O95757, O97125, P02827, P08108, P09435, P09446, P0CB32, P0DMV8, P0DMV9, P0DMW0, P0DMW1, P10591, P10592, P11142, P16019, P17879, P18694, P19120, P19378, P22202, P22953, P24629, P26413, P27322, P27541, P29357, P32589, P32590, P34930, P34931

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 191 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Ovarian tumor domain proteases611.8×3e-03
Selective autophagy59.9×8e-03
SLC transporter disorders68.7×5e-03
R-HSA-42539398.3×6e-04
Disorders of transmembrane transporters76.9×5e-03
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling96.2×3e-03
Clathrin-mediated endocytosis84.8×1e-02
PIP3 activates AKT signaling104.7×5e-03

GO biological processes:

GO termPartnersFoldFDR
regulation of cellular response to heat531.2×3e-04
cellular response to nerve growth factor stimulus513.8×5e-03
cellular response to heat612.2×2e-03
positive regulation of epithelial cell proliferation68.7×8e-03
cell surface receptor protein tyrosine kinase signaling pathway88.2×2e-03
protein autophosphorylation97.7×1e-03
monoatomic ion transport87.4×3e-03
MAPK cascade87.2×3e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

127 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance96
Likely benign8
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

2775 predictions. Top by Δscore:

VariantEffectΔscore
4:127782658:G:GGdonor_gain1.0000
4:127794069:T:Aacceptor_gain1.0000
4:127794131:CCAGG:Cdonor_loss1.0000
4:127794132:CAG:Cdonor_loss1.0000
4:127794133:AGGTA:Adonor_loss1.0000
4:127794134:GGTAA:Gdonor_loss1.0000
4:127794135:GT:Gdonor_loss1.0000
4:127794136:T:Gdonor_loss1.0000
4:127795767:GATA:Gacceptor_gain1.0000
4:127795904:TTAAG:Tdonor_loss1.0000
4:127795905:TAAG:Tdonor_loss1.0000
4:127795906:AAG:Adonor_loss1.0000
4:127795907:AGGTA:Adonor_loss1.0000
4:127795909:G:GCdonor_loss1.0000
4:127795910:T:Adonor_loss1.0000
4:127798582:GTTA:Gacceptor_loss1.0000
4:127798583:TTAG:Tacceptor_loss1.0000
4:127798584:TAGGT:Tacceptor_loss1.0000
4:127798585:A:Tacceptor_loss1.0000
4:127798705:TTTCA:Tdonor_gain1.0000
4:127798706:TTCA:Tdonor_gain1.0000
4:127798706:TTCAG:Tdonor_loss1.0000
4:127798707:TCA:Tdonor_gain1.0000
4:127798708:CA:Cdonor_gain1.0000
4:127798708:CAGTA:Cdonor_loss1.0000
4:127798709:AGTAA:Adonor_loss1.0000
4:127798710:G:GGdonor_gain1.0000
4:127798710:GTAAG:Gdonor_loss1.0000
4:127798711:TAAGT:Tdonor_loss1.0000
4:127801136:A:AGacceptor_gain1.0000

AlphaMissense

5604 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
4:127782634:T:AN28K1.000
4:127782634:T:GN28K1.000
4:127794114:G:AG49R1.000
4:127794114:G:CG49R1.000
4:127794115:G:AG49E1.000
4:127803855:T:AV297D1.000
4:127805689:T:GC380W1.000
4:127811497:T:AV480D1.000
4:127822827:T:AV624D1.000
4:127822831:A:CE625D1.000
4:127822831:A:TE625D1.000
4:127823563:T:CL662P1.000
4:127782563:G:CG5R0.999
4:127782564:G:AG5D0.999
4:127782596:G:CA16P0.999
4:127782597:C:AA16D0.999
4:127782603:C:AA18E0.999
4:127782633:A:TN28I0.999
4:127782641:A:CS31R0.999
4:127782643:C:AS31R0.999
4:127782643:C:GS31R0.999
4:127782648:G:TR33M0.999
4:127794085:T:AI39K0.999
4:127794087:T:CS40P0.999
4:127794115:G:TG49V0.999
4:127794124:C:AA52E0.999
4:127798642:T:CL121P0.999
4:127801183:G:CA159P0.999
4:127801791:T:CL179P0.999
4:127801799:G:AG182R0.999

dbSNP variants (sampled 300 via entrez): RS1000037720 (4:127826736 C>T), RS1000200544 (4:127824245 G>A,T), RS1000229392 (4:127819634 T>C), RS1000260547 (4:127819265 G>A), RS1000380896 (4:127784827 C>T), RS1000381733 (4:127831564 TA>T), RS1000390821 (4:127838576 T>C), RS1000406339 (4:127804651 A>G,T), RS1000470628 (4:127812628 C>T), RS1000489175 (4:127796512 ACATGAATGTT>A), RS1000557403 (4:127826388 C>A,T), RS1000589520 (4:127802017 A>G), RS1000591649 (4:127821114 T>C), RS1000631395 (4:127824579 T>C,G), RS1000734506 (4:127806555 C>A,G)

Disease associations

OMIM: gene MIM:619077 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST005231_28Major depressive disorder5.000000e-06
GCST90002386_4High light scatter reticulocyte percentage of red cells1.000000e-09

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL5465282 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

83 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects cotreatment, increases expression, affects expression8
Benzo(a)pyreneincreases expression5
Aflatoxin B1affects expression, affects cotreatment, increases expression5
sodium arseniteaffects cotreatment, increases expression4
trichostatin Aaffects cotreatment, increases expression3
Acetaminophenincreases expression3
Tobacco Smoke Pollutionincreases expression, affects expression3
Tretinoinincreases expression, decreases expression3
Cyclosporineaffects expression, decreases expression, increases expression3
potassium chromate(VI)affects cotreatment, decreases expression, increases expression2
mercuric bromideincreases expression, affects cotreatment2
entinostatincreases expression, affects cotreatment2
Panobinostataffects cotreatment, increases expression2
Ethanolaffects cotreatment, increases expression2
Cadmiumincreases expression2
Estradiolaffects cotreatment, decreases expression, increases expression2
Phenylmercuric Acetateaffects cotreatment, increases expression2
Silverincreases expression2
Tetrachlorodibenzodioxindecreases expression2
p-Chloromercuribenzoic Acidaffects cotreatment, increases expression2
Particulate Matterincreases reaction, decreases expression, increases abundance, affects expression2
aristolochic acid Idecreases expression1
afuresertibdecreases expression1
methylmercuric chlorideincreases expression1
bisphenol Aincreases expression1
lead acetateaffects cotreatment, increases expression1
methylselenic acidincreases expression1
pyrogallol 1,3-dimethyl etheraffects cotreatment, affects localization, decreases expression1
Nonidet P-40increases expression1
2-methyl-4-isothiazolin-3-oneincreases expression1

ChEMBL screening assays

2 unique, capped per target: 2 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL5338469BindingBinding affinity to Hspa4l (unknown origin) assessed as fold change in protein upregulation at 200 uM preincubated for 2 hrs followed by pronase addition and measured after 30 mins by coomassie blue staining based SDS-PAGE gel analysisStructurally Diverse Alkaloids with Anti-Renal-Fibrosis Activity from the Centipede Scolopendra subspinipes mutilans. — J Nat Prod

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.